Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 6/20 | 0.35 |
| ▸ | CNR2 | P34972 | 3/20 | 0.33 |
| ▸ | SYK | P43405 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | F2R | P25116 | 1/20 | 0.33 |
| ▸ | CD69 | Q07108 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20683066 | 0.87 | BTK (0.39) | BTKCNR2GAACD69ALDH1A1 | |
| SCHEMBL29766427 | 0.87 | BTK (0.39) | BTKCNR2GAACD69ALDH1A1 | |
| SCHEMBL26073300 | 0.86 | BTK (0.34) | BTKCNR2GAAF2RCD69 | |
| SCHEMBL29766231 | 0.86 | BTK (0.34) | BTKCNR2GAAF2RCD69 | |
| SCHEMBL25489102 | 0.86 | BTK (0.34) | BTKCNR2GAAF2RCD69 | |
| SCHEMBL29766403 | 0.83 | BTK (0.36) | BTKCNR2ALDH1A1TSHRCYP3A4 | |
| SCHEMBL20683056 | 0.83 | BTK (0.36) | BTKCNR2ALDH1A1TSHRCYP3A4 | |
| SCHEMBL20683042 | 0.79 | KMT2A (0.34) | BTKALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL20533283 | 0.75 | BTK (0.34) | BTK | |
| SCHEMBL30522345 | 0.75 | BTK (0.34) | BTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4249071-A2 | BENZOAZEPINE ANALOGS AS INHIBITING AGENTS FOR BRUTON'S TYROSINE KINASE | Biogen MA Inc. (US) | 2023-09-27 | — | — | EP | disclosed |